240 related articles for article (PubMed ID: 11691821)
1. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB
Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine.
Buchegger F; Vieira JM; Blaeuenstein P; Dupertuis YM; Schaffland AO; Grannavel C; de Tribolet N; Slosman DO; Bischof Delaloye A
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):239-46. PubMed ID: 12552342
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
5. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
6. Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.
Perillo-Adamer F; Delaloye AB; Genton CS; Schaffland AO; Dupertuis YM; Buchegger F
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):613-20. PubMed ID: 16450135
[TBL] [Abstract][Full Text] [Related]
7. 18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd.
Viertl D; Perillo-Adamer F; André PA; Ametamey SM; Ross TL; Kosinski M; Dupertuis YM; Bischof Delaloye A; Buchegger F
Nuklearmedizin; 2012; 51(5):163-9. PubMed ID: 22576273
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
[TBL] [Abstract][Full Text] [Related]
10. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
[TBL] [Abstract][Full Text] [Related]
11. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
Schaffland AO; Delaloye AB; Kosinski M; Dupertuis YM; Buchegger F
Nucl Med Commun; 2004 May; 25(5):461-8. PubMed ID: 15100504
[TBL] [Abstract][Full Text] [Related]
12. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
[TBL] [Abstract][Full Text] [Related]
14. Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography.
Viertl D; Bischof Delaloye A; Lanz B; Poitry-Yamate C; Gruetter R; Mlynarik V; Ametamey SM; Ross TL; Lehr HA; André PA; Perillo-Adamer F; Kosinski M; Dupertuis YM; Buchegger F
Mol Imaging Biol; 2011 Apr; 13(2):321-31. PubMed ID: 20556524
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the activation of fluorodeoxyuridine by substrate competition and feedback inhibition in 647V cells.
Vazquez-Padua MA; Risueno C; Fischer PH
Cancer Res; 1989 Feb; 49(3):618-24. PubMed ID: 2521299
[TBL] [Abstract][Full Text] [Related]
16. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
[TBL] [Abstract][Full Text] [Related]
17. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.
Benson AB; Trump DL; Cummings KB; Fischer PH
Biochem Pharmacol; 1985 Nov; 34(21):3925-31. PubMed ID: 2933042
[TBL] [Abstract][Full Text] [Related]
19. Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.
Kassis AI; Van den Abbeele AD; Wen PY; Baranowska-Kortylewicz J; Aaronson RA; DeSisto WC; Lampson LA; Black PM; Adelstein SJ
Cancer Res; 1990 Aug; 50(16):5199-203. PubMed ID: 2379179
[TBL] [Abstract][Full Text] [Related]
20. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]